GENFIT
Develops therapies and diagnostics for patients with rare and severe liver diseases.
GNFT | PA
Overview
Corporate Details
- ISIN(s):
- FR0004163111 (+2 more)
- LEI:
- 969500XPWN2DMZQA5X73
- Country:
- France
- Address:
- 885 AVENUE EUGENE AVINEE, 59120 LOOS
- Website:
- https://www.genfit.com
Description
GENFIT is a biopharmaceutical company dedicated to developing therapeutic and diagnostic solutions for patients with rare and severe liver diseases characterized by high unmet medical needs. The company's primary focus is on Acute-on-Chronic Liver Failure (ACLF) and its associated conditions, such as acute decompensation (AD) and hepatic encephalopathy (HE). Leveraging a scientific heritage of over two decades, GENFIT is a pioneer in liver disease research and development, aiming to improve the lives of patients with these life-threatening conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2018-05-31 18:13 |
2018.05.31 PR GENFIT - Pascal Prigent
|
English | 305.4 KB | ||
| 2018-05-31 18:13 |
2018.05.31 CP GENFIT - Pascal Prigent
|
French | 244.1 KB | ||
| 2018-05-09 17:55 |
2018.05.09 PR Availability of Shareholders Meeting documents
|
English | 373.7 KB | ||
| 2018-05-09 17:55 |
2018.05.09 CP Mise à disposition documents AG
|
French | 279.4 KB | ||
| 2018-04-27 14:59 |
2018.04.27 PR GENFIT Publication of DDR
|
English | 279.3 KB | ||
| 2018-04-27 14:59 |
2018.04.27 CP GENFIT Mise à disposition DDR
|
French | 189.0 KB | ||
| 2018-04-23 07:59 |
2018.04.23 PR GENFIT - DSMB RESOLVE-IT
|
English | 294.1 KB | ||
| 2018-04-23 07:59 |
2018.04.23 CP GENFIT - DSMB RESOLVE-IT
|
French | 251.1 KB | ||
| 2018-04-11 07:28 |
2018.04.11 PR GENFIT RESOLVE-IT
|
English | 348.5 KB | ||
| 2018-04-11 07:28 |
2018.04.11 CP GENFIT RESOLVE-IT
|
French | 258.7 KB | ||
| 2018-03-28 13:40 |
2018.03.28 PR GENFIT EASL ILC 2018
|
English | 317.3 KB | ||
| 2018-03-28 13:40 |
2018.03.28 CP GENFIT EASL ILC 2018
|
French | 478.8 KB | ||
| 2018-01-23 08:39 |
2018.01.23 CP GENFIT PSP FDA
|
French | 354.8 KB | ||
| 2018-01-23 08:39 |
2018.01.23 PR GENFIT PSP FDA
|
English | 331.5 KB | ||
| 2018-01-12 17:46 |
2018.01.12 PR GENFIT Half Year report of Liquidity Contract
|
English | 267.0 KB |
Automate Your Workflow. Get a real-time feed of all GENFIT filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GENFIT
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GENFIT via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-07-07 | N/A | Other | Buy | 5,300 | 19,488.10 EUR |
| 2023-07-06 | N/A | Other | Buy | 1,100 | 4,048.00 EUR |
| 2023-07-05 | N/A | Other | Buy | 10,000 | 37,061.00 EUR |
| 2023-07-03 | N/A | Other | Buy | 5,300 | 18,769.95 EUR |
Peer Companies
